Rank | Gene Set | Z-score |
---|---|---|
1 | regulation of apoptotic cell clearance (GO:2000425) | 5.94316106 |
2 | complement activation, alternative pathway (GO:0006957) | 5.74588616 |
3 | apoptotic cell clearance (GO:0043277) | 5.74054113 |
4 | protein carboxylation (GO:0018214) | 5.05320730 |
5 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.05320730 |
6 | opsonization (GO:0008228) | 4.57168311 |
7 | barbed-end actin filament capping (GO:0051016) | 4.54966388 |
8 | regulation of integrin activation (GO:0033623) | 4.48480724 |
9 | regulation of complement activation (GO:0030449) | 4.39608168 |
10 | regulation of protein activation cascade (GO:2000257) | 4.29341087 |
11 | cell adhesion mediated by integrin (GO:0033627) | 4.01181966 |
12 | mannose metabolic process (GO:0006013) | 3.88109924 |
13 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 3.87100528 |
14 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.85484980 |
15 | type B pancreatic cell proliferation (GO:0044342) | 3.77737797 |
16 | peptide cross-linking (GO:0018149) | 3.76505517 |
17 | regulation of integrin-mediated signaling pathway (GO:2001044) | 3.74856268 |
18 | protein localization to endosome (GO:0036010) | 3.74472483 |
19 | negative regulation of fibrinolysis (GO:0051918) | 3.71980408 |
20 | regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035358) | 3.67303002 |
21 | cell migration involved in heart development (GO:0060973) | 3.67007402 |
22 | complement activation (GO:0006956) | 3.63472461 |
23 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.60750678 |
24 | keratinization (GO:0031424) | 3.60180290 |
25 | fibril organization (GO:0097435) | 3.56199010 |
26 | positive regulation of hemostasis (GO:1900048) | 3.55032824 |
27 | positive regulation of blood coagulation (GO:0030194) | 3.55032824 |
28 | hyaluronan catabolic process (GO:0030214) | 3.53972873 |
29 | endothelial cell chemotaxis (GO:0035767) | 3.48253300 |
30 | lipoxygenase pathway (GO:0019372) | 3.45969242 |
31 | extracellular fibril organization (GO:0043206) | 3.45716886 |
32 | fibrinolysis (GO:0042730) | 3.44881754 |
33 | low-density lipoprotein particle clearance (GO:0034383) | 3.43425126 |
34 | collagen metabolic process (GO:0032963) | 3.42216280 |
35 | 4-hydroxyproline metabolic process (GO:0019471) | 3.40147781 |
36 | negative regulation of smooth muscle cell migration (GO:0014912) | 3.37960702 |
37 | positive regulation of coagulation (GO:0050820) | 3.37074153 |
38 | substrate-dependent cell migration (GO:0006929) | 3.36700397 |
39 | adhesion of symbiont to host (GO:0044406) | 3.36368532 |
40 | glycosphingolipid catabolic process (GO:0046479) | 3.36278430 |
41 | collagen catabolic process (GO:0030574) | 3.35278968 |
42 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.35039929 |
43 | regulation of early endosome to late endosome transport (GO:2000641) | 3.33845995 |
44 | COPI coating of Golgi vesicle (GO:0048205) | 3.33265481 |
45 | Golgi transport vesicle coating (GO:0048200) | 3.33265481 |
46 | stress fiber assembly (GO:0043149) | 3.32752108 |
47 | pinocytosis (GO:0006907) | 3.32263328 |
48 | skin morphogenesis (GO:0043589) | 3.31406763 |
49 | decidualization (GO:0046697) | 3.30716756 |
50 | sequestering of extracellular ligand from receptor (GO:0035581) | 3.26908336 |
51 | detection of molecule of bacterial origin (GO:0032490) | 3.24840354 |
52 | hemidesmosome assembly (GO:0031581) | 3.22783595 |
53 | virion attachment to host cell (GO:0019062) | 3.20186728 |
54 | adhesion of symbiont to host cell (GO:0044650) | 3.20186728 |
55 | glial cell migration (GO:0008347) | 3.18414983 |
56 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.18119223 |
57 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 3.18009348 |
58 | plasma lipoprotein particle clearance (GO:0034381) | 3.17692184 |
59 | cellular response to interferon-alpha (GO:0035457) | 3.16953018 |
60 | endodermal cell differentiation (GO:0035987) | 3.14464619 |
61 | multicellular organismal macromolecule metabolic process (GO:0044259) | 3.10644816 |
62 | regulation of fibrinolysis (GO:0051917) | 3.09540417 |
63 | peptidyl-proline hydroxylation (GO:0019511) | 3.07703616 |
64 | regulation of macrophage chemotaxis (GO:0010758) | 3.07317801 |
65 | regulation of humoral immune response (GO:0002920) | 3.06621119 |
66 | multicellular organismal catabolic process (GO:0044243) | 3.04356146 |
67 | basement membrane organization (GO:0071711) | 3.04002121 |
68 | regulation of endothelial cell chemotaxis (GO:2001026) | 3.02683294 |
69 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.02235589 |
70 | positive regulation of osteoblast proliferation (GO:0033690) | 3.02222811 |
71 | extracellular matrix disassembly (GO:0022617) | 3.01842472 |
72 | complement activation, classical pathway (GO:0006958) | 3.00432868 |
73 | protein activation cascade (GO:0072376) | 2.97286630 |
74 | chondrocyte proliferation (GO:0035988) | 2.97188810 |
75 | glycolipid catabolic process (GO:0019377) | 2.96790423 |
76 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.95071868 |
77 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.93501978 |
78 | urea metabolic process (GO:0019627) | 2.91190528 |
79 | urea cycle (GO:0000050) | 2.91190528 |
80 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.91027839 |
81 | multicellular organismal metabolic process (GO:0044236) | 2.90280258 |
82 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.90196262 |
83 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.89884436 |
84 | collagen fibril organization (GO:0030199) | 2.87587908 |
85 | platelet degranulation (GO:0002576) | 2.85590531 |
86 | endocytic recycling (GO:0032456) | 2.85320314 |
87 | alpha-linolenic acid metabolic process (GO:0036109) | 2.81241268 |
88 | regulation of plasminogen activation (GO:0010755) | 2.81065394 |
89 | citrulline biosynthetic process (GO:0019240) | 2.79429195 |
90 | negative regulation of nitric-oxide synthase activity (GO:0051001) | 2.78964200 |
91 | hypotonic response (GO:0006971) | 2.77174438 |
92 | protein retention in ER lumen (GO:0006621) | 2.76641413 |
93 | regulation of monocyte chemotaxis (GO:0090025) | 2.75519436 |
94 | negative regulation of focal adhesion assembly (GO:0051895) | 2.75430251 |
95 | negative regulation of cell junction assembly (GO:1901889) | 2.75430251 |
96 | negative regulation of adherens junction organization (GO:1903392) | 2.75430251 |
97 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.74655695 |
98 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.73021204 |
99 | endothelial cell morphogenesis (GO:0001886) | 2.72780619 |
100 | L-phenylalanine metabolic process (GO:0006558) | 2.71481146 |
101 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.71481146 |
102 | tooth mineralization (GO:0034505) | 2.69298588 |
103 | regulation of extracellular matrix disassembly (GO:0010715) | 2.69241870 |
104 | regulation of chemokine biosynthetic process (GO:0045073) | 2.68380751 |
105 | nitrogen cycle metabolic process (GO:0071941) | 2.66645463 |
106 | response to laminar fluid shear stress (GO:0034616) | 2.65624157 |
107 | kidney mesenchyme development (GO:0072074) | 2.65095488 |
108 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.63805092 |
109 | epoxygenase P450 pathway (GO:0019373) | 2.63631086 |
110 | ceramide catabolic process (GO:0046514) | 2.63562542 |
111 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.61956441 |
112 | L-phenylalanine catabolic process (GO:0006559) | 2.61956441 |
113 | positive regulation of extracellular matrix organization (GO:1903055) | 2.61892138 |
114 | cellular response to vitamin (GO:0071295) | 2.61264607 |
115 | sulfur amino acid catabolic process (GO:0000098) | 2.61090470 |
116 | amino sugar catabolic process (GO:0046348) | 2.60709798 |
117 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.60577811 |
118 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.60003224 |
119 | response to magnesium ion (GO:0032026) | 2.59311472 |
120 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.58745414 |
121 | regulation of cholesterol storage (GO:0010885) | 2.58428660 |
122 | regulation of smooth muscle cell migration (GO:0014910) | 2.58053731 |
123 | bone trabecula formation (GO:0060346) | 2.57743878 |
124 | regulation of phagocytosis (GO:0050764) | 2.56152362 |
125 | venous blood vessel morphogenesis (GO:0048845) | 2.55427906 |
126 | chondroitin sulfate catabolic process (GO:0030207) | 2.55350854 |
127 | chronic inflammatory response (GO:0002544) | 2.54676550 |
128 | positive regulation of phagocytosis (GO:0050766) | 2.54626931 |
129 | positive regulation of receptor recycling (GO:0001921) | 2.54255659 |
130 | regulation of collagen metabolic process (GO:0010712) | 2.54220957 |
131 | embryo implantation (GO:0007566) | 2.52882392 |
132 | positive regulation of cell adhesion mediated by integrin (GO:0033630) | 2.52246917 |
133 | response to thyroid hormone (GO:0097066) | 2.52088366 |
134 | oligosaccharide catabolic process (GO:0009313) | 2.51565904 |
135 | cytokine production involved in immune response (GO:0002367) | 2.50574826 |
136 | negative regulation of platelet activation (GO:0010544) | 2.48201358 |
137 | sphingolipid catabolic process (GO:0030149) | 2.47836635 |
138 | membrane lipid catabolic process (GO:0046466) | 2.47313484 |
139 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.47182355 |
140 | keratan sulfate catabolic process (GO:0042340) | 2.47118796 |
141 | protein hydroxylation (GO:0018126) | 2.46796147 |
142 | extracellular matrix organization (GO:0030198) | 2.45900806 |
143 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.45548312 |
144 | sphingosine metabolic process (GO:0006670) | 2.45373787 |
145 | extracellular structure organization (GO:0043062) | 2.44898958 |
146 | positive regulation of p38MAPK cascade (GO:1900745) | 2.44443840 |
147 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.44311561 |
148 | positive regulation of wound healing (GO:0090303) | 2.43486719 |
149 | keratinocyte differentiation (GO:0030216) | 2.43202448 |
150 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.42957517 |
151 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.42274742 |
152 | cell-substrate junction assembly (GO:0007044) | 2.41794759 |
153 | epithelial cell-cell adhesion (GO:0090136) | 2.41700662 |
154 | extracellular regulation of signal transduction (GO:1900115) | 2.41411240 |
155 | detection of external biotic stimulus (GO:0098581) | 2.40754758 |
156 | regulation of mononuclear cell migration (GO:0071675) | 2.39341160 |
157 | protein targeting to plasma membrane (GO:0072661) | 2.38829187 |
158 | wound healing (GO:0042060) | 2.36587537 |
159 | phospholipid efflux (GO:0033700) | 2.33775852 |
160 | L-ascorbic acid metabolic process (GO:0019852) | 2.33755381 |
161 | extracellular matrix assembly (GO:0085029) | 2.33672763 |
162 | regulation of natural killer cell differentiation (GO:0032823) | 2.33538804 |
163 | lipoprotein metabolic process (GO:0042157) | 2.31988307 |
164 | high-density lipoprotein particle remodeling (GO:0034375) | 2.31737004 |
165 | membrane raft organization (GO:0031579) | 2.30830039 |
166 | bile acid biosynthetic process (GO:0006699) | 2.30674259 |
167 | wound healing, spreading of epidermal cells (GO:0035313) | 2.27968360 |
168 | aldehyde catabolic process (GO:0046185) | 2.25888687 |
169 | regulation of cholesterol homeostasis (GO:2000188) | 2.25824388 |
170 | glyoxylate metabolic process (GO:0046487) | 2.25210462 |
171 | positive regulation of fatty acid metabolic process (GO:0045923) | 2.24599582 |
172 | xenobiotic catabolic process (GO:0042178) | 2.24496645 |
173 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.24315201 |
174 | protein heterotrimerization (GO:0070208) | 2.23819117 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 5.88396931 |
2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.85914436 |
3 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 4.62964767 |
4 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 4.19557266 |
5 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.67357587 |
6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.45554808 |
7 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.23515201 |
8 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 3.13647323 |
9 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.85649507 |
10 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.85336596 |
11 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.72921070 |
12 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.38074716 |
13 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.23329330 |
14 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 2.22712505 |
15 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.19949190 |
16 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 2.13432503 |
17 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.12711687 |
18 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 2.11527163 |
19 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.94726608 |
20 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.94579032 |
21 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.90947676 |
22 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.89322881 |
23 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.88093529 |
24 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.84973195 |
25 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.84927913 |
26 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.75273987 |
27 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.72618596 |
28 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.68272396 |
29 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.60590419 |
30 | CJUN_26792858_Chip-Seq_BT549_Human | 1.59820099 |
31 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.59782446 |
32 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.57071431 |
33 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.54761339 |
34 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.53196610 |
35 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.49058504 |
36 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.46898108 |
37 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.46561520 |
38 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.45578185 |
39 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.44734482 |
40 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.43365378 |
41 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.42873225 |
42 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.40133061 |
43 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.37233201 |
44 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.37233201 |
45 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.36341097 |
46 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.35896851 |
47 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.35480698 |
48 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.35064790 |
49 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.30682096 |
50 | KDM2B_26808549_Chip-Seq_K562_Human | 1.29717625 |
51 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.28653506 |
52 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.26821531 |
53 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.26131376 |
54 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.25429377 |
55 | ATF3_27146783_Chip-Seq_COLON_Human | 1.25010345 |
56 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.24706800 |
57 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.24706800 |
58 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.23666792 |
59 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.23044167 |
60 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.22497431 |
61 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.21105952 |
62 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.20573525 |
63 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.19724940 |
64 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.19719271 |
65 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.19132719 |
66 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.18636529 |
67 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.16574706 |
68 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.14925060 |
69 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.14347854 |
70 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.13192412 |
71 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.10736446 |
72 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.10144058 |
73 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.10108608 |
74 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.09760722 |
75 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.06740886 |
76 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.06728102 |
77 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.06541252 |
78 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.05598446 |
79 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.03222863 |
80 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.03101032 |
81 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.02808153 |
82 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.02776396 |
83 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.02212472 |
84 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.01502855 |
85 | SA1_22415368_ChIP-Seq_MEFs_Mouse | 1.01461523 |
86 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.01153714 |
87 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.00183414 |
88 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.99970795 |
89 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.99759461 |
90 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.99402020 |
91 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.99349709 |
92 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.99040787 |
93 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.98021599 |
94 | SPI1_23127762_ChIP-Seq_K562_Human | 0.97773718 |
95 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.97721091 |
96 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.97324201 |
97 | * SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.97070791 |
98 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.96510285 |
99 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.96510285 |
100 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.93541346 |
101 | GATA1_19941826_ChIP-Seq_K562_Human | 0.93434908 |
102 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.93412077 |
103 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.93393630 |
104 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.93233455 |
105 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.92980273 |
106 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.92426964 |
107 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.92406506 |
108 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.91753580 |
109 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.91735699 |
110 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.91053223 |
111 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.90966507 |
112 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.89627211 |
113 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.89456192 |
114 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.87977312 |
115 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.87954104 |
116 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.87609524 |
117 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.86829927 |
118 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.86479631 |
119 | BRD4_25478319_ChIP-Seq_HGPS_Human | 0.86344998 |
120 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.86337544 |
121 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.85675335 |
122 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.83435656 |
123 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.82499254 |
124 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.82236189 |
125 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.81159961 |
126 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.81071219 |
127 | TP53_16413492_ChIP-PET_HCT116_Human | 0.79693986 |
128 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.79532981 |
129 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.79067938 |
130 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.79038284 |
131 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.78799365 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0008438_abnormal_cutaneous_collagen | 5.81345268 |
2 | MP0003705_abnormal_hypodermis_morpholog | 4.66918381 |
3 | MP0005275_abnormal_skin_tensile | 3.73315535 |
4 | MP0005257_abnormal_intraocular_pressure | 3.26235454 |
5 | MP0003279_aneurysm | 2.86219187 |
6 | MP0005503_abnormal_tendon_morphology | 2.62130238 |
7 | MP0005360_urolithiasis | 2.59298659 |
8 | MP0009840_abnormal_foam_cell | 2.46009593 |
9 | MP0003566_abnormal_cell_adhesion | 2.36171026 |
10 | MP0001958_emphysema | 2.34057817 |
11 | MP0010368_abnormal_lymphatic_system | 2.32128572 |
12 | MP0005023_abnormal_wound_healing | 2.24929476 |
13 | MP0002139_abnormal_hepatobiliary_system | 2.21480751 |
14 | MP0005058_abnormal_lysosome_morphology | 2.13466776 |
15 | MP0003436_decreased_susceptibility_to | 2.08053936 |
16 | MP0003806_abnormal_nucleotide_metabolis | 2.06841117 |
17 | MP0009384_cardiac_valve_regurgitation | 2.03016244 |
18 | MP0004272_abnormal_basement_membrane | 1.98668588 |
19 | MP0005365_abnormal_bile_salt | 1.85993846 |
20 | MP0001533_abnormal_skeleton_physiology | 1.84230761 |
21 | MP0002060_abnormal_skin_morphology | 1.81027736 |
22 | MP0003172_abnormal_lysosome_physiology | 1.80464706 |
23 | MP0006082_CNS_inflammation | 1.77874037 |
24 | MP0003724_increased_susceptibility_to | 1.76079335 |
25 | MP0002138_abnormal_hepatobiliary_system | 1.66808026 |
26 | MP0006054_spinal_hemorrhage | 1.65900897 |
27 | MP0005085_abnormal_gallbladder_physiolo | 1.64500217 |
28 | MP0008875_abnormal_xenobiotic_pharmacok | 1.59958332 |
29 | MP0010352_gastrointestinal_tract_polyps | 1.54509529 |
30 | MP0010234_abnormal_vibrissa_follicle | 1.52163383 |
31 | MP0000751_myopathy | 1.50419098 |
32 | MP0002295_abnormal_pulmonary_circulatio | 1.47453971 |
33 | MP0003252_abnormal_bile_duct | 1.45141046 |
34 | MP0003191_abnormal_cellular_cholesterol | 1.39702837 |
35 | MP0004947_skin_inflammation | 1.38542099 |
36 | MP0000343_altered_response_to | 1.36931986 |
37 | MP0005171_absent_coat_pigmentation | 1.35652920 |
38 | MP0010329_abnormal_lipoprotein_level | 1.34607142 |
39 | MP0005390_skeleton_phenotype | 1.31903083 |
40 | MP0000767_abnormal_smooth_muscle | 1.30043538 |
41 | MP0003300_gastrointestinal_ulcer | 1.28798642 |
42 | MP0001243_abnormal_dermal_layer | 1.26544644 |
43 | MP0003075_altered_response_to | 1.25861658 |
44 | MP0003091_abnormal_cell_migration | 1.25220018 |
45 | MP0002933_joint_inflammation | 1.24471538 |
46 | MP0005083_abnormal_biliary_tract | 1.23548816 |
47 | MP0002419_abnormal_innate_immunity | 1.18909215 |
48 | MP0005451_abnormal_body_composition | 1.16810283 |
49 | MP0005332_abnormal_amino_acid | 1.12938871 |
50 | MP0000249_abnormal_blood_vessel | 1.12061922 |
51 | MP0005508_abnormal_skeleton_morphology | 1.11502502 |
52 | MP0005464_abnormal_platelet_physiology | 1.10910893 |
53 | MP0005623_abnormal_meninges_morphology | 1.10543672 |
54 | MP0004858_abnormal_nervous_system | 1.09854783 |
55 | MP0003303_peritoneal_inflammation | 1.06804446 |
56 | MP0000609_abnormal_liver_physiology | 1.03291674 |
57 | MP0000685_abnormal_immune_system | 1.03285902 |
58 | MP0005501_abnormal_skin_physiology | 1.03095383 |
59 | MP0001849_ear_inflammation | 1.02859222 |
60 | MP0005387_immune_system_phenotype | 1.02278927 |
61 | MP0001790_abnormal_immune_system | 1.02278927 |
62 | MP0000604_amyloidosis | 1.01914769 |
63 | MP0009764_decreased_sensitivity_to | 1.01382118 |
64 | MP0005319_abnormal_enzyme/_coenzyme | 0.99305349 |
65 | MP0009053_abnormal_anal_canal | 0.99123125 |
66 | MP0001851_eye_inflammation | 0.98029811 |
67 | MP0001542_abnormal_bone_strength | 0.97353265 |
68 | MP0005025_abnormal_response_to | 0.95064136 |
69 | MP0003828_pulmonary_edema | 0.93858516 |
70 | MP0002168_other_aberrant_phenotype | 0.93232449 |
71 | MP0005164_abnormal_response_to | 0.92380389 |
72 | MP0003195_calcinosis | 0.92187871 |
73 | MP0002998_abnormal_bone_remodeling | 0.91829127 |
74 | MP0003453_abnormal_keratinocyte_physiol | 0.91707415 |
75 | MP0002108_abnormal_muscle_morphology | 0.90790969 |
76 | MP0002254_reproductive_system_inflammat | 0.90747971 |
77 | MP0003186_abnormal_redox_activity | 0.90495823 |
78 | MP0001879_abnormal_lymphatic_vessel | 0.89845003 |
79 | MP0001915_intracranial_hemorrhage | 0.89338847 |
80 | MP0008260_abnormal_autophagy | 0.89149022 |
81 | MP0002796_impaired_skin_barrier | 0.88446053 |
82 | MP0003941_abnormal_skin_development | 0.87459353 |
83 | MP0003795_abnormal_bone_structure | 0.86201625 |
84 | MP0005165_increased_susceptibility_to | 0.85959423 |
85 | MP0003448_altered_tumor_morphology | 0.85387226 |
86 | MP0002148_abnormal_hypersensitivity_rea | 0.84638013 |
87 | MP0002166_altered_tumor_susceptibility | 0.83927097 |
88 | MP0009763_increased_sensitivity_to | 0.83599655 |
89 | MP0009643_abnormal_urine_homeostasis | 0.82988429 |
90 | MP0002896_abnormal_bone_mineralization | 0.82720274 |
91 | MP0000750_abnormal_muscle_regeneration | 0.82565741 |
92 | MP0000013_abnormal_adipose_tissue | 0.82238970 |
93 | MP0002118_abnormal_lipid_homeostasis | 0.82021692 |
94 | MP0008004_abnormal_stomach_pH | 0.81548011 |
95 | MP0004883_abnormal_blood_vessel | 0.81110452 |
96 | MP0000858_altered_metastatic_potential | 0.80886167 |
97 | MP0005409_darkened_coat_color | 0.79161661 |
98 | MP0008469_abnormal_protein_level | 0.79022641 |
99 | MP0004019_abnormal_vitamin_homeostasis | 0.78707230 |
100 | MP0009785_altered_susceptibility_to | 0.78151632 |
101 | MP0005000_abnormal_immune_tolerance | 0.77323271 |
102 | MP0009278_abnormal_bone_marrow | 0.76965651 |
103 | MP0000733_abnormal_muscle_development | 0.76933762 |
104 | MP0010030_abnormal_orbit_morphology | 0.76530540 |
105 | MP0002282_abnormal_trachea_morphology | 0.76394039 |
106 | MP0002128_abnormal_blood_circulation | 0.76191998 |
107 | MP0000467_abnormal_esophagus_morphology | 0.76164771 |
108 | MP0009333_abnormal_splenocyte_physiolog | 0.76134180 |
109 | MP0000749_muscle_degeneration | 0.75828093 |
110 | MP0001845_abnormal_inflammatory_respons | 0.75757499 |
111 | MP0001614_abnormal_blood_vessel | 0.75631047 |
112 | MP0004510_myositis | 0.75496121 |
113 | MP0009780_abnormal_chondrocyte_physiolo | 0.74979243 |
114 | MP0002877_abnormal_melanocyte_morpholog | 0.74979175 |
115 | MP0003950_abnormal_plasma_membrane | 0.74746876 |
116 | MP0005595_abnormal_vascular_smooth | 0.74508091 |
117 | MP0005197_abnormal_uvea_morphology | 0.74248545 |
118 | MP0001853_heart_inflammation | 0.72846365 |
119 | MP0001216_abnormal_epidermal_layer | 0.72780552 |
120 | MP0002136_abnormal_kidney_physiology | 0.72260498 |
121 | MP0010386_abnormal_urinary_bladder | 0.72213791 |
122 | MP0000371_diluted_coat_color | 0.71848464 |
123 | MP0000598_abnormal_liver_morphology | 0.71700775 |
124 | MP0000759_abnormal_skeletal_muscle | 0.71618442 |
125 | MP0010771_integument_phenotype | 0.71561990 |
126 | MP0000920_abnormal_myelination | 0.71067421 |
127 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.70353964 |
128 | MP0002405_respiratory_system_inflammati | 0.69457067 |
129 | MP0001299_abnormal_eye_distance/ | 0.68098577 |
130 | MP0002113_abnormal_skeleton_development | 0.67549652 |
131 | MP0003634_abnormal_glial_cell | 0.66360717 |
132 | MP0009250_abnormal_appendicular_skeleto | 0.65299755 |
133 | MP0000163_abnormal_cartilage_morphology | 0.65155115 |
134 | MP0005166_decreased_susceptibility_to | 0.63783316 |
135 | MP0000003_abnormal_adipose_tissue | 0.63055431 |
136 | MP0000747_muscle_weakness | 0.59191286 |
137 | MP0005193_abnormal_anterior_eye | 0.58917615 |
138 | MP0002089_abnormal_postnatal_growth/wei | 0.57198181 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Protrusio acetabuli (HP:0003179) | 6.61768221 |
2 | Systemic lupus erythematosus (HP:0002725) | 6.03645696 |
3 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.96456594 |
4 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.96456594 |
5 | Abnormality of glycolipid metabolism (HP:0010969) | 4.96456594 |
6 | Premature rupture of membranes (HP:0001788) | 4.82950491 |
7 | Abnormality of complement system (HP:0005339) | 4.64206299 |
8 | Complement deficiency (HP:0004431) | 4.63651197 |
9 | Peritonitis (HP:0002586) | 4.47707814 |
10 | Vertebral compression fractures (HP:0002953) | 4.28175039 |
11 | Deep venous thrombosis (HP:0002625) | 4.22652055 |
12 | Glomerulonephritis (HP:0000099) | 4.15732912 |
13 | Shallow orbits (HP:0000586) | 4.11763324 |
14 | Follicular hyperkeratosis (HP:0007502) | 3.86921004 |
15 | Cerebral aneurysm (HP:0004944) | 3.65621280 |
16 | Cervical subluxation (HP:0003308) | 3.58857645 |
17 | Atrophic scars (HP:0001075) | 3.55867897 |
18 | Aortic aneurysm (HP:0004942) | 3.55148809 |
19 | Broad metatarsal (HP:0001783) | 3.52261626 |
20 | Aortic dissection (HP:0002647) | 3.41969393 |
21 | Vascular tortuosity (HP:0004948) | 3.34064831 |
22 | Spondylolisthesis (HP:0003302) | 3.28865264 |
23 | Arterial tortuosity (HP:0005116) | 3.27915243 |
24 | Dysostosis multiplex (HP:0000943) | 3.21316171 |
25 | Vacuolated lymphocytes (HP:0001922) | 3.13650894 |
26 | Nuclear cataract (HP:0100018) | 3.10091518 |
27 | Slender build (HP:0001533) | 3.07830208 |
28 | Nephritis (HP:0000123) | 3.06555326 |
29 | Xanthomatosis (HP:0000991) | 3.05193064 |
30 | Biconcave vertebral bodies (HP:0004586) | 3.04346994 |
31 | Joint stiffness (HP:0001387) | 3.03498850 |
32 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.92850409 |
33 | Mitral stenosis (HP:0001718) | 2.91410689 |
34 | Wrist flexion contracture (HP:0001239) | 2.88264188 |
35 | Achilles tendon contracture (HP:0001771) | 2.84536053 |
36 | Mucopolysacchariduria (HP:0008155) | 2.81918119 |
37 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.81918119 |
38 | Abnormality of the common coagulation pathway (HP:0010990) | 2.80619170 |
39 | Short nail (HP:0001799) | 2.67770310 |
40 | Dilatation of the ascending aorta (HP:0005111) | 2.65931559 |
41 | Wormian bones (HP:0002645) | 2.65148905 |
42 | Beaking of vertebral bodies (HP:0004568) | 2.61891861 |
43 | Fragile skin (HP:0001030) | 2.60984601 |
44 | Prolonged partial thromboplastin time (HP:0003645) | 2.60632224 |
45 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.59994882 |
46 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.59994882 |
47 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.59994882 |
48 | Asymmetric septal hypertrophy (HP:0001670) | 2.58889785 |
49 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.57275665 |
50 | Coxa vara (HP:0002812) | 2.55201271 |
51 | Increased connective tissue (HP:0009025) | 2.54326637 |
52 | Soft skin (HP:0000977) | 2.53533730 |
53 | Abnormality of the Achilles tendon (HP:0005109) | 2.53000958 |
54 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.51904039 |
55 | Aneurysm (HP:0002617) | 2.51866613 |
56 | Increased variability in muscle fiber diameter (HP:0003557) | 2.50730712 |
57 | Blue sclerae (HP:0000592) | 2.46998097 |
58 | Neonatal short-limb short stature (HP:0008921) | 2.45422248 |
59 | Myocardial infarction (HP:0001658) | 2.43199113 |
60 | Hand muscle atrophy (HP:0009130) | 2.40698663 |
61 | Right ventricular cardiomyopathy (HP:0011663) | 2.37744154 |
62 | Upper limb amyotrophy (HP:0009129) | 2.36949031 |
63 | Distal upper limb amyotrophy (HP:0007149) | 2.36949031 |
64 | Cardiovascular calcification (HP:0011915) | 2.35614373 |
65 | Abnormality of the acetabulum (HP:0003170) | 2.34995641 |
66 | Spinal rigidity (HP:0003306) | 2.31408653 |
67 | Menorrhagia (HP:0000132) | 2.30761445 |
68 | Generalized amyotrophy (HP:0003700) | 2.30292116 |
69 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.27639847 |
70 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.26417612 |
71 | Ectopia lentis (HP:0001083) | 2.25992590 |
72 | Osteolytic defects of the hand bones (HP:0009699) | 2.22788480 |
73 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.22788480 |
74 | Ankle contracture (HP:0006466) | 2.22714855 |
75 | Joint hemorrhage (HP:0005261) | 2.20598584 |
76 | Abnormality of dentin (HP:0010299) | 2.18750257 |
77 | Hypoalphalipoproteinemia (HP:0003233) | 2.17431445 |
78 | Bladder diverticulum (HP:0000015) | 2.15754307 |
79 | Amyloidosis (HP:0011034) | 2.14450009 |
80 | Bowel diverticulosis (HP:0005222) | 2.11434180 |
81 | Mitral valve prolapse (HP:0001634) | 2.09768746 |
82 | Joint laxity (HP:0001388) | 2.08933313 |
83 | Esophageal varix (HP:0002040) | 2.08889163 |
84 | Bronchomalacia (HP:0002780) | 2.08573360 |
85 | Distal lower limb amyotrophy (HP:0008944) | 2.08540687 |
86 | Natal tooth (HP:0000695) | 2.07933174 |
87 | Axonal loss (HP:0003447) | 2.06655452 |
88 | Mitral regurgitation (HP:0001653) | 2.05593729 |
89 | Intrahepatic cholestasis (HP:0001406) | 2.04008491 |
90 | Hyperextensible skin (HP:0000974) | 2.00825234 |
91 | Long toe (HP:0010511) | 1.99492360 |
92 | Aortic regurgitation (HP:0001659) | 1.98169316 |
93 | Loss of speech (HP:0002371) | 1.97399800 |
94 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.95163860 |
95 | Neurofibrillary tangles (HP:0002185) | 1.95021590 |
96 | Vascular calcification (HP:0004934) | 1.91276578 |
97 | Aortic valve stenosis (HP:0001650) | 1.91143935 |
98 | J-shaped sella turcica (HP:0002680) | 1.90149487 |
99 | Abnormal delivery (HP:0001787) | 1.87765091 |
100 | Hypoventilation (HP:0002791) | 1.86643373 |
101 | Emphysema (HP:0002097) | 1.84320507 |
102 | Thin bony cortex (HP:0002753) | 1.84316957 |
103 | Ovoid vertebral bodies (HP:0003300) | 1.83586520 |
104 | Abnormality of the lumbar spine (HP:0100712) | 1.82415345 |
105 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.79862847 |
106 | Abnormality of the peritoneum (HP:0002585) | 1.79248369 |
107 | Type 1 muscle fiber predominance (HP:0003803) | 1.78883284 |
108 | Eczematoid dermatitis (HP:0000976) | 1.77333465 |
109 | Overgrowth (HP:0001548) | 1.76818996 |
110 | Femoral bowing (HP:0002980) | 1.76641723 |
111 | Distal lower limb muscle weakness (HP:0009053) | 1.75746151 |
112 | Elbow flexion contracture (HP:0002987) | 1.74876186 |
113 | Ulnar deviation of the wrist (HP:0003049) | 1.74870919 |
114 | Hypolipoproteinemia (HP:0010981) | 1.74440430 |
115 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.74051826 |
116 | Nonimmune hydrops fetalis (HP:0001790) | 1.73094829 |
117 | Hyperlipoproteinemia (HP:0010980) | 1.72808075 |
118 | Flat acetabular roof (HP:0003180) | 1.70997750 |
119 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.70997119 |
120 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.70359997 |
121 | Interstitial pulmonary disease (HP:0006530) | 1.69423332 |
122 | Polycythemia (HP:0001901) | 1.69403464 |
123 | Striae distensae (HP:0001065) | 1.68586042 |
124 | Round ear (HP:0100830) | 1.68549067 |
125 | Abnormality of the intrinsic pathway (HP:0010989) | 1.68545272 |
126 | Ulnar bowing (HP:0003031) | 1.67901007 |
127 | Disproportionate tall stature (HP:0001519) | 1.67616920 |
128 | Spontaneous hematomas (HP:0007420) | 1.67212660 |
129 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.66659075 |
130 | Hyperacusis (HP:0010780) | 1.66333672 |
131 | Turricephaly (HP:0000262) | 1.64925593 |
132 | Camptodactyly of toe (HP:0001836) | 1.64644842 |
133 | Osteopenia (HP:0000938) | 1.63950027 |
134 | Genu recurvatum (HP:0002816) | 1.63654781 |
135 | Progressive neurologic deterioration (HP:0002344) | 1.62256818 |
136 | Increased cerebral lipofuscin (HP:0011813) | 1.62217892 |
137 | Thoracolumbar scoliosis (HP:0002944) | 1.61398985 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ERN1 | 4.99151228 |
2 | MST1R | 4.34684035 |
3 | TRIB3 | 3.57914770 |
4 | EPHA2 | 3.41012312 |
5 | IRAK3 | 3.05670347 |
6 | PKN2 | 2.63607254 |
7 | TTN | 2.51420816 |
8 | TGFBR2 | 2.37682310 |
9 | MET | 2.28057690 |
10 | GRK7 | 2.08369356 |
11 | EPHB1 | 2.03867778 |
12 | EPHB2 | 2.01223218 |
13 | BLK | 2.01197122 |
14 | RIPK1 | 1.98054568 |
15 | BMX | 1.81767226 |
16 | FGFR4 | 1.78329978 |
17 | PIM2 | 1.76583778 |
18 | LATS2 | 1.63644756 |
19 | CDC42BPA | 1.62548919 |
20 | TRPM7 | 1.61453977 |
21 | PTK6 | 1.61043649 |
22 | SIK1 | 1.56129261 |
23 | ARAF | 1.54834786 |
24 | PTK2 | 1.52155010 |
25 | TESK1 | 1.46417946 |
26 | MAP3K3 | 1.45343543 |
27 | CAMK1D | 1.44379206 |
28 | LRRK2 | 1.41884955 |
29 | MAP3K11 | 1.38828605 |
30 | TYK2 | 1.38790797 |
31 | MAP2K3 | 1.37568704 |
32 | PRKD2 | 1.35991650 |
33 | FER | 1.31807322 |
34 | NME2 | 1.31352073 |
35 | MAPKAPK3 | 1.29415817 |
36 | PDGFRA | 1.28827820 |
37 | TBK1 | 1.28150707 |
38 | DDR2 | 1.24480583 |
39 | EPHA3 | 1.23338889 |
40 | MAP3K6 | 1.18445735 |
41 | ICK | 1.18245026 |
42 | STK10 | 1.16076713 |
43 | KDR | 1.14107209 |
44 | TAOK3 | 1.13459693 |
45 | RPS6KA4 | 1.13304093 |
46 | PIK3CG | 1.12276166 |
47 | ZAP70 | 1.11198815 |
48 | PRPF4B | 1.06640175 |
49 | FLT3 | 1.06208647 |
50 | TGFBR1 | 1.05432357 |
51 | BCKDK | 1.03826792 |
52 | LIMK1 | 1.02391594 |
53 | PTK2B | 0.99293134 |
54 | ERBB3 | 0.96682695 |
55 | CSK | 0.96619472 |
56 | STK38 | 0.92398303 |
57 | PAK4 | 0.91322368 |
58 | NEK9 | 0.89187476 |
59 | FGFR1 | 0.88153870 |
60 | ERBB4 | 0.87277932 |
61 | PAK2 | 0.86338444 |
62 | FRK | 0.83677437 |
63 | MAP4K1 | 0.83613403 |
64 | CAMK1G | 0.77962941 |
65 | PRKG2 | 0.77595309 |
66 | HCK | 0.77543766 |
67 | KIT | 0.76360279 |
68 | PAK3 | 0.76257081 |
69 | RPS6KA2 | 0.75176693 |
70 | DAPK3 | 0.74306735 |
71 | MAP3K12 | 0.74007420 |
72 | JAK1 | 0.72970999 |
73 | LMTK2 | 0.72188169 |
74 | JAK3 | 0.71549252 |
75 | LATS1 | 0.69625796 |
76 | MYLK | 0.69516692 |
77 | MAP2K1 | 0.69287132 |
78 | MOS | 0.68094746 |
79 | PAK1 | 0.67561081 |
80 | PAK6 | 0.66316112 |
81 | ABL2 | 0.66111081 |
82 | MAPK7 | 0.65027411 |
83 | NTRK1 | 0.64111763 |
84 | DMPK | 0.62779665 |
85 | DAPK2 | 0.62228394 |
86 | KSR2 | 0.62133477 |
87 | IGF1R | 0.61703132 |
88 | MAP3K2 | 0.60694548 |
89 | ADRBK2 | 0.60600336 |
90 | TAOK1 | 0.59864466 |
91 | ROCK2 | 0.59549040 |
92 | CDK6 | 0.59493433 |
93 | PRKCH | 0.58628744 |
94 | PRKD1 | 0.57619210 |
95 | EEF2K | 0.57588152 |
96 | ADRBK1 | 0.57212831 |
97 | MUSK | 0.56019138 |
98 | MAP3K7 | 0.53981166 |
99 | TAOK2 | 0.53300906 |
100 | MAP3K14 | 0.53232196 |
101 | MAP3K13 | 0.52321850 |
102 | SIK3 | 0.52286178 |
103 | CLK1 | 0.51325504 |
104 | STK3 | 0.51112099 |
105 | DYRK1B | 0.50620460 |
106 | MATK | 0.49223488 |
107 | GRK5 | 0.48632260 |
108 | EGFR | 0.48532655 |
109 | BRAF | 0.47203443 |
110 | TESK2 | 0.46136198 |
111 | MAP3K1 | 0.43920775 |
112 | ERBB2 | 0.43888145 |
113 | IKBKB | 0.42947590 |
114 | TIE1 | 0.41279697 |
115 | MAP3K8 | 0.39722774 |
116 | MAP3K5 | 0.39369547 |
117 | CAMKK1 | 0.38898887 |
118 | MAPKAPK2 | 0.38809172 |
119 | PIK3CA | 0.38139566 |
120 | CHUK | 0.37674633 |
121 | ILK | 0.37202546 |
122 | CAMK2G | 0.36403689 |
123 | GRK6 | 0.36304852 |
124 | RET | 0.35823635 |
125 | SRC | 0.35701368 |
126 | ROCK1 | 0.35222341 |
127 | MTOR | 0.35160722 |
128 | PDGFRB | 0.34814250 |
129 | PRKD3 | 0.34325819 |
130 | MAPK12 | 0.33234233 |
131 | MARK2 | 0.33001760 |
132 | PDPK1 | 0.32936244 |
133 | JAK2 | 0.31172795 |
134 | CDK15 | 0.30775980 |
135 | GSK3A | 0.29372023 |
136 | INSR | 0.29202432 |
137 | CDK11A | 0.29051632 |
138 | CDK14 | 0.28399539 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 4.66048473 |
2 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 3.86246329 |
3 | Other glycan degradation_Homo sapiens_hsa00511 | 2.81847269 |
4 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.45557157 |
5 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.41600183 |
6 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.37694557 |
7 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.28676605 |
8 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.07973322 |
9 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.99481351 |
10 | Malaria_Homo sapiens_hsa05144 | 1.99202297 |
11 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.94556858 |
12 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.84817360 |
13 | Pertussis_Homo sapiens_hsa05133 | 1.83431864 |
14 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.79641153 |
15 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.75350537 |
16 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.74300851 |
17 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.67688513 |
18 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.65835205 |
19 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.55049044 |
20 | Lysosome_Homo sapiens_hsa04142 | 1.53006047 |
21 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.52911471 |
22 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.44394796 |
23 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.42317695 |
24 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.42214526 |
25 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.41036965 |
26 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.40768238 |
27 | Amoebiasis_Homo sapiens_hsa05146 | 1.40361471 |
28 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.40183113 |
29 | Histidine metabolism_Homo sapiens_hsa00340 | 1.26523486 |
30 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.26282521 |
31 | Leishmaniasis_Homo sapiens_hsa05140 | 1.24515219 |
32 | Prion diseases_Homo sapiens_hsa05020 | 1.24282762 |
33 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.20469070 |
34 | Focal adhesion_Homo sapiens_hsa04510 | 1.18037539 |
35 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.17202830 |
36 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.16820674 |
37 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.12671055 |
38 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.10231140 |
39 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.07159834 |
40 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.05954354 |
41 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.05867794 |
42 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.05369323 |
43 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.05249364 |
44 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.03610053 |
45 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.00822761 |
46 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.00077184 |
47 | Phagosome_Homo sapiens_hsa04145 | 0.96159480 |
48 | Peroxisome_Homo sapiens_hsa04146 | 0.95179589 |
49 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.92809489 |
50 | Bile secretion_Homo sapiens_hsa04976 | 0.92654731 |
51 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.92270526 |
52 | Shigellosis_Homo sapiens_hsa05131 | 0.91783992 |
53 | Endocytosis_Homo sapiens_hsa04144 | 0.90123709 |
54 | Bladder cancer_Homo sapiens_hsa05219 | 0.88707910 |
55 | Legionellosis_Homo sapiens_hsa05134 | 0.85979260 |
56 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.85868898 |
57 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.85808234 |
58 | Adherens junction_Homo sapiens_hsa04520 | 0.83428069 |
59 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.82283841 |
60 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.81405637 |
61 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.80895221 |
62 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.80699506 |
63 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.79341305 |
64 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.79287148 |
65 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.79156408 |
66 | Retinol metabolism_Homo sapiens_hsa00830 | 0.77960301 |
67 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.77743009 |
68 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.76763889 |
69 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.76722172 |
70 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.76680575 |
71 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.75565978 |
72 | Influenza A_Homo sapiens_hsa05164 | 0.75144497 |
73 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.74243578 |
74 | Hepatitis B_Homo sapiens_hsa05161 | 0.73189203 |
75 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.72235143 |
76 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.71427200 |
77 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.70042462 |
78 | Hepatitis C_Homo sapiens_hsa05160 | 0.69995212 |
79 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.69993699 |
80 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.69930440 |
81 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.68886172 |
82 | Melanoma_Homo sapiens_hsa05218 | 0.68853276 |
83 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.68841400 |
84 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.68713327 |
85 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.67868105 |
86 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.66316880 |
87 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.66160338 |
88 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.65924591 |
89 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.65276477 |
90 | Tuberculosis_Homo sapiens_hsa05152 | 0.65177171 |
91 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.64543157 |
92 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.63600287 |
93 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.63583465 |
94 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.63239705 |
95 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.62847632 |
96 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.62054155 |
97 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.61492944 |
98 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.60683204 |
99 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.60139117 |
100 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.59739386 |
101 | Salmonella infection_Homo sapiens_hsa05132 | 0.59492701 |
102 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.59327107 |
103 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.59321416 |
104 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.58855148 |
105 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.58486472 |
106 | Glioma_Homo sapiens_hsa05214 | 0.58062039 |
107 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.57442388 |
108 | Platelet activation_Homo sapiens_hsa04611 | 0.55874730 |
109 | Pathways in cancer_Homo sapiens_hsa05200 | 0.55823079 |
110 | Carbon metabolism_Homo sapiens_hsa01200 | 0.55487356 |
111 | Asthma_Homo sapiens_hsa05310 | 0.55084042 |
112 | Viral myocarditis_Homo sapiens_hsa05416 | 0.54264173 |
113 | Lysine degradation_Homo sapiens_hsa00310 | 0.51857852 |
114 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.51801694 |
115 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.51494742 |
116 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.51362351 |
117 | ABC transporters_Homo sapiens_hsa02010 | 0.51334577 |
118 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.51209756 |
119 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.50386207 |
120 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.50190913 |
121 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.49583331 |
122 | Prostate cancer_Homo sapiens_hsa05215 | 0.49415170 |
123 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.49157401 |
124 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.48589393 |
125 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.48554956 |
126 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.47779745 |
127 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.47228980 |
128 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.46377588 |
129 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.46230215 |
130 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.46080581 |
131 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.45756281 |
132 | Apoptosis_Homo sapiens_hsa04210 | 0.44378032 |
133 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.44141186 |
134 | Insulin resistance_Homo sapiens_hsa04931 | 0.44131840 |
135 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.44050779 |
136 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.43920791 |
137 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.43575098 |
138 | Mineral absorption_Homo sapiens_hsa04978 | 0.43212330 |
139 | HTLV-I infection_Homo sapiens_hsa05166 | 0.42840924 |
140 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.41259363 |
141 | Sulfur relay system_Homo sapiens_hsa04122 | 0.40233626 |
142 | Allograft rejection_Homo sapiens_hsa05330 | 0.39835077 |
143 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.39774859 |
144 | Galactose metabolism_Homo sapiens_hsa00052 | 0.39587408 |
145 | Gap junction_Homo sapiens_hsa04540 | 0.39310874 |
146 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.38846971 |
147 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.38804926 |
148 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.38593601 |
149 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.38236098 |
150 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.38076652 |
151 | Thyroid cancer_Homo sapiens_hsa05216 | 0.37193890 |